Intellia Therapeutics NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Market Optimism ARCO Q1 2026 Earnings Strong EPS Beat Overshadowed by Stock Decline CDZIP Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline Amid Water Resource Development CXDO Q1 2026 Earnings EPS Surprises 256 Above Estimates VEL Q1 2026 Earnings EPS Beats Estimates but Stock Dips 217 REKR Q1 2026 Earnings WiderThanExpected Loss Stuns Investors